Evelo Biosciences, Inc., a biotechnology company, focuses on the development of monocolonal microbials for the treatment of inflammatory diseases and cancer. It is involved in developing EDP1066 and EDP1815, which are in Phase 1b placebo-controlled dose-escalating safety and tolerability clinical study for the treatment of atopic dermatitis, asthma, psoriatic arthritis, rheumatoid arthritis, and inflammatory bowel diseases. The company is also involved in developing EDP150, a monoclonal microbial candidate, which is in Phase 1/2 clinical study for the treatment of colorectal cancer, triple-negative breast cancer, and melanoma, as well as patients who have relapsed on prior PD-1/L1 inhibitor treatment across multiple tumor types. Evelo Biosciences, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [02/20/2020 07:40 PST] EVLO Expected to Trade Up Short Term
• [02/19/2020 10:48 PST] Evelo Biosciences, Inc. (NASDAQ:EVLO), Up By 100.00% ($5.53) From $5.530 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/19/2020 07:28 PST] EVLO Expected to Trade Up After Bullish Patterns Develop
• [02/18/2020 10:10 PST] Evelo Biosciences, Inc. (NASDAQ:EVLO), Up By 100.00% ($4.70) From $4.700 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/14/2020 12:23 PST] Evelo Biosciences, Inc. (NASDAQ:EVLO), Up By 100.00% ($4.39) From $4.390 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/14/2020 07:46 PST] EVLO Expected to Trade Up After Bullish Patterns Develop
• [02/11/2020 07:21 PST] EVLO Expected to Trade Up After Bullish Patterns Develop
• [01/29/2020 10:10 PST] Evelo Biosciences, Inc. (NASDAQ:EVLO), Up By 100.00% ($6.01) From $6.010 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/29/2020 10:10 PST] Evelo Biosciences, Inc. (NASDAQ:EVLO), Up By 100.00% ($6.01) From $6.010 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/27/2020 07:47 PST] EVLO Expected to Trade Up After Bullish Patterns Develop
• [01/24/2020 07:30 PST] EVLO Expected to Trade Up After Bullish Patterns Develop
• [01/06/2020 07:33 PST] EVLO Expected to Trade Down After Bearish Patterns Develop